News
UK biotechs T-Therapeutics and Alethio score big financings
Two up-and-coming UK biotechs – T-Therapeutics and Alethio Therapeutics – have raised $133m and $90m, respectively, in impressive financing rounds.
News
Boehringer forges $7bn alliance with China's SBP Group
Boehringer Ingelheim is paying $358m upfront for options on up to six antibody-drug conjugates and T-cell engagers from China's Sino Biopharma.
R&D
Why the best CROs challenge the trial plan and keep challeng...
Too often, oncology trials fail for reasons that could have been anticipated and addressed.
News
AbbVie invests £120m in UK expansion
AbbVie has pledged another £120 million to the UK, reinforcing the country's recovery as a pharma industry investment hotspot.
News
German sites added to Europe's cardiometabolic R&D network
The BioInnovation Institute (BII) has expanded a European network to develop drugs for cardiometabolic diseases and launch new biotechs into Germany.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
